Copyright
©The Author(s) 2019.
World J Gastroenterol. Oct 7, 2019; 25(37): 5578-5589
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5578
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5578
Table 2 Preliminary effects of developing vaccines against Helicobacter pylori infection
Vaccine | Prophylactic | Therapeutic |
EpiVax/Helicobacter pylori vaccine | Yes | Yes |
Helicovaxor® | Yes | No |
Imevax/IMX101 | Yes | No |
Wuhu Kangwei Biological Technology | Yes | No |
- Citation: de Brito BB, da Silva FAF, Soares AS, Pereira VA, Santos MLC, Sampaio MM, Neves PHM, de Melo FF. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019; 25(37): 5578-5589
- URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5578.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5578